<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Clinical presentation and diagnosis of retroperitoneal soft tissue sarcoma
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Clinical presentation and diagnosis of retroperitoneal soft tissue sarcoma
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Clinical presentation and diagnosis of retroperitoneal soft tissue sarcoma
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John T Mullen, MD, FACS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth H Baldini, MD, MPH, FASTRO
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert Maki, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Raphael E Pollock, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Melinda Yushak, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn A Collins, MD, PhD, FACS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 23, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sarcomas are malignant tumors that arise from skeletal and extraskeletal connective tissues. Most soft tissue sarcomas (STS) present in the extremities, but many other sites can be affected, including the retroperitoneum, chest wall, head and neck, and subcutaneous tissues.
        </p>
        <p>
         The clinical presentation and diagnosis of retroperitoneal STS are discussed here. The initial management of retroperitoneal STS and the management of locally recurrent retroperitoneal STS are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/142600.html" rel="external">
          "Initial management of retroperitoneal soft tissue sarcoma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/115829.html" rel="external">
          "Management of locally recurrent retroperitoneal sarcoma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3427592713">
         <span class="h1">
          ANATOMY OF THE RETROPERITONEUM
         </span>
         <span class="headingEndMark">
          —
         </span>
         The retroperitoneum is the space just posterior to the peritoneal cavity and anterior to the paraspinous musculature. The paraspinous musculature includes the psoas major, psoas minor, quadratus lumborum, obturator internus, and pyriformis. Superiorly, the retroperitoneum is bordered by the diaphragm and, inferiorly, it forms a natural extension to the pelvis (pelvic diaphragm) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         The structures of the retroperitoneum  (
         <a class="graphic graphic_figure graphicRef117050" href="/z/d/graphic/117050.html" rel="external">
          figure 1
         </a>
         ) include the kidneys, adrenal glands, and perirenal fat bilaterally, the aorta and its branches (eg, renal arteries), the inferior vena cava and its tributaries (eg, renal veins), and the bilateral iliac vessels (common, internal, external iliac arteries/veins), as well as the third portion of the duodenum and pancreas. The ascending and descending colon are considered partially retroperitoneal.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retroperitoneal soft tissue sarcomas (STS) are rare cancers that make up approximately 10 to 15 percent of all STS [
         <a href="#rid2">
          2
         </a>
         ]. The average annual incidence is approximately 2.7 cases per million people [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3523954120">
         <span class="h1">
          CLINICAL PRESENTATION
         </span>
        </p>
        <p class="headingAnchor" id="H2004705113">
         <span class="h2">
          Age and sex
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retroperitoneal soft tissue sarcomas (STS) usually present in patients in their 50s but can occur at any age [
         <a href="#rid4">
          4-6
         </a>
         ]. Retroperitoneal STS is diagnosed with equal frequency in males and females.
        </p>
        <p class="headingAnchor" id="H3135279608">
         <span class="h2">
          Clinical symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retroperitoneal STS typically does not cause symptoms until the tumor is large enough to compress or invade surrounding anatomic structures. Most tumors are already large and locally advanced when they are initially detected, with a median size at diagnosis of approximately 15 cm [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         Some patients may present with an incidental abdominal mass that is asymptomatic or minimally symptomatic. Others may present with abdominal pain and/or symptoms related to mass effect of the tumor on surrounding structures, such as:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lower extremity edema due to compression of retroperitoneal venous structures. (See
         <a class="medical medical_review" href="/z/d/html/15223.html" rel="external">
          "Overview of iliocaval venous obstruction"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Referred pain to the groin or lower extremities due to compression or local invasion of the retroperitoneal nerves  (
         <a class="graphic graphic_figure graphicRef63993" href="/z/d/graphic/63993.html" rel="external">
          figure 2
         </a>
         ) or musculoskeletal structures.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Weight loss, early satiety, and/or bowel obstruction due to compression or local invasion of the gastrointestinal tract.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serous ascites due to portal venous compression [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Other clinical symptoms include fevers, night sweats, flu-like symptoms, and weight loss in patients with high-grade, rapidly expanding tumors [
         <a href="#rid7">
          7,9
         </a>
         ]. Rarely, retroperitoneal STS may present with paraneoplastic hypoglycemia, which is usually secondary to tumor production of "big" insulin-like growth factor 2 (IGF-2) [
         <a href="#rid7">
          7,8,10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1780.html" rel="external">
          "Nonislet cell tumor hypoglycemia"
         </a>
         .)
        </p>
        <p>
         Distant metastases are present at the time of diagnosis in approximately 10 percent of patients [
         <a href="#rid11">
          11
         </a>
         ]. The most common sites of disease include the lung and the liver. (See
         <a class="medical medical_review" href="/z/d/html/14259.html" rel="external">
          "Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma", section on 'Pattern of spread'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4067658564">
         <span class="h2">
          Physical exam
         </span>
         <span class="headingEndMark">
          —
         </span>
         The physical examination should include palpation of all lymph node basins and an abdominal exam, which may demonstrate an abdominal mass. Other potential findings may include ascites, hepatic masses or lower extremity edema. (See
         <a class="medical medical_review" href="/z/d/html/6862.html" rel="external">
          "Evaluation of the adult with abdominal pain"
         </a>
         .)
        </p>
        <p>
         Male patients with a retroperitoneal mass should also undergo a careful testicular examination to assess for a mass (with follow-up testicular ultrasound as indicated), since testicular cancer can metastasize to the retroperitoneal nodes. (See
         <a class="medical medical_review" href="/z/d/html/2980.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of testicular germ cell tumors", section on 'Testicular examination'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2544933350">
         <span class="h1">
          DIAGNOSTIC EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H2757852258">
         <span class="h2">
          When to suspect the diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of retroperitoneal soft tissue sarcomas (STS) should be suspected in patients with a retroperitoneal mass that is unifocal and extravisceral on imaging studies and without clinical evidence for an alternative cancer diagnosis (eg, no widespread lymphadenopathy concerning for lymphoma; no clinical or imaging evidence of a testicular mass; no elevated tumor markers specific to a germ cell tumor).
        </p>
        <p>
         Most neoplasms that arise within the retroperitoneal space are malignant (80 percent). Furthermore, most patients who present with a primary retroperitoneal, extravisceral, unifocal soft tissue mass will be found to have a sarcoma. A careful diagnostic evaluation is necessary to distinguish between retroperitoneal STS and other conditions.
        </p>
        <p class="headingAnchor" id="H1217387115">
         <span class="h2">
          Differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis for a retroperitoneal mass includes lymphoma, a primary germ cell tumor, or metastatic testicular cancer. Cancers originating in the duodenum, pancreas, adrenal glands, or kidney can be distinguished from retroperitoneal STS using imaging studies, as the former tumors arise from their respective organs whereas retroperitoneal soft tissue masses are extravisceral. (See
         <a class="medical medical_review" href="/z/d/html/2980.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of testicular germ cell tumors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2998.html" rel="external">
          "Extragonadal germ cell tumors involving the mediastinum and retroperitoneum"
         </a>
         .)
        </p>
        <p>
         The differential diagnosis also includes schwannomas and paragangliomas, particularly for retroperitoneal masses located in the midline adjacent to the aorta or vena cava. (See
         <a class="medical medical_review" href="/z/d/html/15269.html" rel="external">
          "Peripheral nerve tumors", section on 'Schwannoma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5231.html" rel="external">
          "Paragangliomas: Epidemiology, clinical presentation, diagnosis, and histology"
         </a>
         .)
        </p>
        <p>
         Two typically benign processes, Castleman disease (angiofollicular lymph node hyperplasia) and retroperitoneal fibrosis, arise within the retroperitoneum and can mimic retroperitoneal STS both clinically and radiographically. (See
         <a class="medical medical_review" href="/z/d/html/90340.html" rel="external">
          "Unicentric Castleman disease"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7200.html" rel="external">
          "Clinical manifestations and diagnosis of retroperitoneal fibrosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2919807888">
         <span class="h2">
          Imaging studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients with a retroperitoneal mass must undergo imaging studies to further characterize the mass and assess for resectability.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Computed tomography
         </strong>
         – We obtain a computed tomography (CT) scan of the abdomen and pelvis with both oral and intravenous contrast to evaluate the primary tumor site and a CT scan of the chest to assess for metastatic disease to the lungs. (See
         <a class="medical medical_review" href="/z/d/html/14259.html" rel="external">
          "Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma", section on 'Pattern of spread'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         CT is preferred to magnetic resonance imaging (MRI) to evaluate the primary tumor. In most cases, CT is less sensitive to motion artifact than MRI, and it better defines the anatomic relationship of the tumor to other abdominal organs. It can also detect metastases to the liver or peritoneum. The radiographic appearance of the primary tumor on a CT scan can also offer clues as to the histologic subtype and grade, which may guide decisions as to the need for a pretreatment biopsy as well as treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          MRI
         </strong>
         – For patients with an allergy to intravenous CT iodinated contrast agent, MRI of the abdomen and pelvis with gadolinium contrast may be obtained in addition to or as an alternative to a non-contrast enhanced CT abdomen and pelvis. For those with an initial CT that demonstrates equivocal muscle, vessel, bone, or foraminal involvement, and/or for some pelvic tumors, a follow-up MRI of the abdomen and pelvis may better delineate tumor involvement of these structures [
         <a href="#rid12">
          12
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14259.html" rel="external">
          "Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma", section on 'MRI and CT'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Positron emission tomography (PET)-CT imaging is not routinely used for the initial work-up of a retroperitoneal soft tissue mass. Further details are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14259.html" rel="external">
          "Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma", section on 'PET and PET/CT'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4024874657">
         <span class="h2">
          Laboratory studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         We obtain a complete blood count with differential and a lactate dehydrogenase (LDH) level. A complete blood count with differential is used to assess for leukocytosis, which can be seen in some patients with rapidly expanding tumors [
         <a href="#rid7">
          7,9
         </a>
         ] (see
         <a class="local">
          'Clinical symptoms'
         </a>
         above). An isolated LDH in the context of lymphadenopathy may also be suggestive of lymphoma. (See
         <a class="medical medical_review" href="/z/d/html/2980.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of testicular germ cell tumors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4688.html" rel="external">
          "Clinical presentation and diagnosis of classic Hodgkin lymphoma in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4695.html" rel="external">
          "Clinical presentation and initial evaluation of non-Hodgkin lymphoma"
         </a>
         .)
        </p>
        <p>
         For patients in whom germ cell tumor is in the differential diagnosis, laboratory studies should include measurement of LDH, alpha-fetoprotein (AFP), and beta-human chorionic gonadotropin (beta-hCG). If elevated, these tumor markers would raise the suspicion for a germ cell tumor. (See
         <a class="medical medical_review" href="/z/d/html/2980.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of testicular germ cell tumors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4688.html" rel="external">
          "Clinical presentation and diagnosis of classic Hodgkin lymphoma in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4695.html" rel="external">
          "Clinical presentation and initial evaluation of non-Hodgkin lymphoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2704123060">
         <span class="h2">
          Diagnostic biopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of retroperitoneal STS is confirmed through diagnostic biopsy with histopathologic analysis demonstrating sarcoma. (See
         <a class="local">
          'Histopathology'
         </a>
         below.)
        </p>
        <p>
         For most patients with suspected retroperitoneal STS, we strongly prefer to obtain tissue using an image-guided percutaneous core needle biopsy rather than proceeding directly to surgery. Obtaining a core needle biopsy allows confirmation of the diagnosis and specific histology prior to initiating treatment (such as neoadjuvant therapy). This approach is safe and does not increase the risk of local recurrence or decrease overall survival [
         <a href="#rid13">
          13,14
         </a>
         ]. Tumor seeding of the biopsy tract is rare [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         Initial surgery without biopsy (for both pathologic diagnosis and treatment) is an alternative in very select situations, such as patients suspected to have well-differentiated liposarcoma based on initial imaging studies who will not receive neoadjuvant (preoperative) therapy. Patients who are being evaluated for this approach must receive multidisciplinary evaluation at a high-volume sarcoma center so that the risks and benefits of initial surgery versus other approaches (ie, neoadjuvant therapy) can be discussed by medical oncology, radiation oncology, and surgical oncology. Further details are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/116605.html" rel="external">
          "Surgical resection of retroperitoneal sarcoma", section on 'Imaging and pathology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/142600.html" rel="external">
          "Initial management of retroperitoneal soft tissue sarcoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2379341350">
         <span class="h1">
          HISTOPATHOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H353302995">
         <span class="h2">
          Adults
         </span>
         <span class="headingEndMark">
          —
         </span>
         In adults, the most common histologic types of retroperitoneal soft tissue sarcomas (STS) are liposarcoma and leiomyosarcoma, followed by undifferentiated/unclassified STS, a subset of which is differentiated pleomorphic sarcoma. Other histologic types may be observed in the retroperitoneum, but they are less common.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Liposarcomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among the different variants of liposarcoma that present in the retroperitoneum, the most common are well-differentiated (low-grade) liposarcomas, followed by dedifferentiated liposarcomas. Myxoid, round cell, and pleomorphic liposarcomas are uncommonly found in the retroperitoneum. (See
         <a class="medical medical_review" href="/z/d/html/14259.html" rel="external">
          "Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma", section on 'Most common subtypes'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Well-differentiated liposarcoma
         </strong>
         – Microscopically, well-differentiated liposarcomas consist of a background of adipocytes that contain scattered lipoblasts, each with a single atypical nucleus surrounded by large intracytoplasmic vacuoles. There is often an inflammatory cell infiltrate. Hypercellular well-differentiated liposarcomas may be confused with dedifferentiated liposarcomas [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Well-differentiated liposarcomas that arise in the body wall/trunk or extremity are referred to as atypical lipomatous tumors since they do not metastasize to distant organs [
         <a href="#rid17">
          17
         </a>
         ]. However, these tumors do have a propensity for local recurrence in the retroperitoneum/mediastinum and spermatic cord [
         <a href="#rid17">
          17
         </a>
         ]. Although not common, well-differentiated liposarcoma can also recur as a dedifferentiated liposarcoma, which is more aggressive in nature. For example, a well-differentiated liposarcoma that contains areas of sclerosis or inflammatory changes may be at higher risk for locoregional recurrence or regrowth as a dedifferentiated liposarcoma than a well-differentiated liposarcoma that is purely lipoma-like [
         <a href="#rid18">
          18,19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dedifferentiated liposarcoma
         </strong>
         –
         <strong>
         </strong>
         Dedifferentiated liposarcomas are defined by the presence of sharply demarcated regions of nonlipogenic sarcomatous tissue within a well-differentiated tumor [
         <a href="#rid17">
          17
         </a>
         ]. They may be difficult to distinguish from undifferentiated pleomorphic sarcoma [
         <a href="#rid17">
          17,20-22
         </a>
         ]. Most dedifferentiated liposarcomas are high-grade tumors (grade 2 or 3). Compared with well-differentiated low-grade liposarcomas, they have higher local recurrence rates, the potential to metastasize (distant recurrence rate of 20 to 30 versus 0 percent), and a sixfold higher risk of death [
         <a href="#rid23">
          23,24
         </a>
         ]. It is thought that high-grade dedifferentiated liposarcomas may arise from well-differentiated liposarcomas.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Leiomyosarcomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Leiomyosarcomas (LMS) of the retroperitoneum generally arise from the inferior vena cava, its tributaries, or any small vessel. LMS often presents as a mass or, occasionally, with unilateral or bilateral lower extremity swelling. These tumors are often large at diagnosis. The histopathology of LMS is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3211.html" rel="external">
          "Uterine sarcoma: Classification, epidemiology, clinical manifestations, and diagnosis", section on 'Leiomyosarcoma'
         </a>
         .)
        </p>
        <p>
         In patients with retroperitoneal LMS, lung or liver metastases are sometimes observed at the time of presentation or appear relatively quickly after diagnosis. LMS may also arise from the wall of the gastrointestinal tract or from the uterus. In this situation, they are visceral rather than retroperitoneal, and they have a greater risk of peritoneal spread and metastasis to the liver. (See
         <a class="medical medical_review" href="/z/d/html/3211.html" rel="external">
          "Uterine sarcoma: Classification, epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         For these reasons, surveillance imaging of the lungs and liver is imperative in patients with treated LMS. (See
         <a class="medical medical_review" href="/z/d/html/142600.html" rel="external">
          "Initial management of retroperitoneal soft tissue sarcoma", section on 'Posttreatment follow-up'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1653491227">
         <span class="h3">
          Others
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other less common histologic types that present in the retroperitoneum include undifferentiated/unclassified STS, malignant peripheral nerve sheath tumor, synovial sarcoma, solitary fibrous tumor, and desmoplastic small round cell tumor [
         <a href="#rid25">
          25
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/14259.html" rel="external">
          "Clinical presentation, histopathology, diagnostic evaluation, and staging of soft tissue sarcoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/88706.html" rel="external">
          "Solitary fibrous tumor"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1934012681">
         <span class="h2">
          Children
         </span>
         <span class="headingEndMark">
          —
         </span>
         Among children, the most common histologic types of retroperitoneal sarcomas (RPS) are extraskeletal Ewing sarcoma/primitive neuroectodermal tumor (PNET), alveolar rhabdomyosarcoma, and fibrosarcoma [
         <a href="#rid26">
          26
         </a>
         ]. The clinical presentation of these tumors is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/7744.html" rel="external">
          "Clinical presentation, staging, and prognostic factors of Ewing sarcoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7728.html" rel="external">
          "Rhabdomyosarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          STAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retroperitoneal soft tissue sarcomas (STS) are staged using the eighth edition of the Tumor, Node, Metastasis (TNM) system as defined by the combined American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC). The AJCC/UICC staging system has separate T stage classification (stratified according to size) and prognostic stage groupings for RPS  (
         <a class="graphic graphic_table graphicRef110713" href="/z/d/graphic/110713.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid27">
          27
         </a>
         ]. However, tumor size is not a prognostic factor for retroperitoneal STS [
         <a href="#rid4">
          4,5,20,21,28-30
         </a>
         ].
        </p>
        <p>
         The eighth edition of the AJCC/UICC staging system for retroperitoneal sarcomas (RPS) also includes a nomogram to predict disease-free and overall survival  (
         <a class="graphic graphic_figure graphicRef98038" href="/z/d/graphic/98038.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1563599418">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
        </p>
        <p>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (See
         <a class="medical medical_basics" href="/z/d/html/17046.html" rel="external">
          "Patient education: Soft tissue sarcoma (The Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H181875204">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/119797.html" rel="external">
          "Society guideline links: Soft tissue sarcoma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2511023924">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Common histologies
         </strong>
         – Retroperitoneal soft tissue sarcomas (STS) are rare cancers that make up approximately 10 to 15 percent of all STS. The most common histologies are liposarcoma (both well-differentiated and dedifferentiated) and leiomyosarcoma. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Histopathology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Retroperitoneal STS typically does not cause symptoms until the tumor is large enough to compress or invade surrounding anatomic structures. (See
         <a class="local">
          'Clinical symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Some patients may present with an incidental abdominal mass that is asymptomatic or minimally symptomatic.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Others may present with abdominal pain and/or symptoms related to mass effect of the tumor on surrounding structures, such as lower extremity edema, referred pain to the groin or lower extremities, weight loss, early satiety, bowel obstruction, and serous ascites, among others.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          When to suspect the diagnosis
         </strong>
         – The diagnosis of retroperitoneal STS should be suspected in patients with a retroperitoneal mass that is unifocal and extravisceral on imaging studies and without clinical evidence for an alternative cancer diagnosis such as lymphoma, metastatic testicular cancer, or primary germ cell tumor. (See
         <a class="local">
          'When to suspect the diagnosis'
         </a>
         above and
         <a class="local">
          'Differential diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnostic evaluation
         </strong>
         – The diagnostic workup includes (see
         <a class="local">
          'Diagnostic evaluation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Imaging studies
         </strong>
         – We obtain a computed tomography (CT) scan of the abdomen and pelvis with intravenous and oral contrast to evaluate the primary site as well as a CT scan of the chest to assess for metastatic disease to the lungs. (See
         <a class="local">
          'Imaging studies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         For patients with an allergy to intravenous CT iodinated contrast agents, magnetic resonance imaging (MRI) of the abdomen and pelvis with gadolinium contrast may be obtained in addition to or as an alternative to a non-contrast CT abdomen and pelvis. MRI of the abdomen and pelvis is also an appropriate follow-up study for those with an initial CT that demonstrates equivocal muscle, vessel, bone, or foraminal involvement and/or for some pelvic tumors.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laboratory studies
         </strong>
         – We obtain a complete blood count with differential and a lactate dehydrogenase (LDH) level. For patients where germ cell tumor is in the differential diagnosis, we also obtain alpha-fetoprotein (AFP) and beta-human chorionic gonadotropin (beta-hCG) levels. (See
         <a class="local">
          'Laboratory studies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Diagnostic biopsy
         </strong>
         – The diagnosis of a retroperitoneal STS is confirmed through diagnostic biopsy with histopathologic analysis demonstrating sarcoma. For most patients with suspected retroperitoneal STS, we strongly prefer to obtain tissue using an image-guided percutaneous core needle biopsy rather than proceeding directly to surgery. (See
         <a class="local">
          'Diagnostic biopsy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3231018078">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Thomas F DeLaney, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Liles JS, Tzeng CW, Short JJ, et al. Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg 2009; 46:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raut CP, Pisters PW. Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol 2006; 94:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 2006; 106:1610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer 2001; 92:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer 2004; 100:2448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg 1998; 228:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Storm FK, Mahvi DM. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg 1991; 214:2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kilkenny JW 3rd, Bland KI, Copeland EM 3rd. Retroperitoneal sarcoma: the University of Florida experience. J Am Coll Surg 1996; 182:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss SW, Rao VK. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation". Am J Surg Pathol 1992; 16:1051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strauss G, Christensen L, Zapf J. Tumour-induced hypoglycaemia due to 'big' IGF-II. J Intern Med 1994; 236:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alldinger I, Yang Q, Pilarsky C, et al. Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients. Anticancer Res 2006; 26:1577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Messiou C, Moskovic E, Vanel D, et al. Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm. Eur J Surg Oncol 2017; 43:1191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilkinson MJ, Martin JL, Khan AA, et al. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival. Ann Surg Oncol 2015; 22:853.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Binitie O, Tejiram S, Conway S, et al. Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract. Clin Orthop Relat Res 2013; 471:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berger-Richardson D, Swallow CJ. Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations. Cancer 2017; 123:560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans HL. Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years. Am J Surg Pathol 2007; 31:1.
          </a>
         </li>
         <li class="breakAll">
          Soft tissue and bone tumours. In: WHO Classification of Tumours, 5th ed, WHO Classification of Tumours Editorial Board (Ed), IARC Press, 2020.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keung EZ, Ikoma N, Benjamin R, et al. The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center. J Surg Oncol 2018; 117:1799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kraus MD, Guillou L, Fletcher CD. Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma. Am J Surg Pathol 1997; 21:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perez EA, Gutierrez JC, Moffat FL Jr, et al. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol 2007; 14:1114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nathan H, Raut CP, Thornton K, et al. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system. Ann Surg 2009; 250:970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung L, Lau SK, Jiang Z, et al. Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma. Am J Surg Pathol 2009; 33:1594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol 2008; 15:2739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg 2003; 238:358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Renne SL, Iwenofu OH. Pathology of retroperitoneal sarcomas: A brief review. J Surg Oncol 2018; 117:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pham TH, Iqbal CW, Zarroug AE, et al. Retroperitoneal sarcomas in children: outcomes from an institution. J Pediatr Surg 2007; 42:829.
          </a>
         </li>
         <li class="breakAll">
          Pollock RE, Maki RG, Baldini EH, et al. Soft tissue sarcoma of the retroperitoneum. In: AJCC Cancer Staging Manual, 8th ed, Amin, MB (Eds), AJCC, Chicago 2017. p.531.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg 1995; 221:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997; 15:2832.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Dalen T, Hennipman A, Van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004; 11:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gronchi A, Miceli R, Shurell E, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol 2013; 31:1649.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7736 Version 52.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19414097" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Retroperitoneal and intra-abdominal sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16788949" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Retroperitoneal sarcomas: Combined-modality treatment approaches.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16518798" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11466691" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15160351" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9742918" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2064467" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Diagnosis and management of retroperitoneal soft-tissue sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8605556" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Retroperitoneal sarcoma: the University of Florida experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1471725" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum, and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of "dedifferentiation".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8021581" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Tumour-induced hypoglycaemia due to 'big' IGF-II.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16619574" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Retroperitoneal soft tissue sarcomas: prognosis and treatment of primary and recurrent disease in 117 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28057392" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25190132" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22968531" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Adult soft tissue sarcoma local recurrence after adjuvant treatment without resection of core needle biopsy tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27859013" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17197914" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17197914" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29723411" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9158675" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Well-differentiated inflammatory liposarcoma: an uncommon and easily overlooked variant of a common sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17206483" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19644351" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19574885" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18521685" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : New perspectives for staging and prognosis in soft tissue sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14501502" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29230829" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Pathology of retroperitoneal sarcomas: A brief review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17502193" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Retroperitoneal sarcomas in children: outcomes from an institution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17502193" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Retroperitoneal sarcomas in children: outcomes from an institution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7857146" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9256126" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15078637" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23530096" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
